Mice treated with neo VAX in combination with anti-CTLA-4 or anti-PD-1 displayed enhanced tumor control as compared to control VAX (irrelevant SLP + pI:C) + anti-PD-1 or control VAX + anti-CTLA-4 (Figure 7A). This evidence concerns the gene CTLA4 and neoplasm.